Journalism begins where hype ends

,,

The use of AI is never a purely technical matter: when it enters processes that affect people’s lives, it touches on rights, opportunities, status and freedom"

—Pope Leo XIV

AI Meets Big Pharma: Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery

Isomorphic Labs, founded in 2021 by DeepMind chief Demis Hassabis, has raised $2.1 billion in Series B funding to scale its AI-driven drug discovery platform.

Demis Hassabis’s AI drug discovery startup Isomorphic Labs has raised $2.1 billion in a Thrive Capital-led Series B, joined by Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund.